209 related articles for article (PubMed ID: 26264919)
1. Extracellular volume quantification in isolated hypertension - changes at the detectable limits?
Treibel TA; Zemrak F; Sado DM; Banypersad SM; White SK; Maestrini V; Barison A; Patel V; Herrey AS; Davies C; Caulfield MJ; Petersen SE; Moon JC
J Cardiovasc Magn Reson; 2015 Aug; 17(1):74. PubMed ID: 26264919
[TBL] [Abstract][Full Text] [Related]
2. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
3. Novel Index of Maladaptive Myocardial Remodeling in Hypertension.
Goh VJ; Le TT; Bryant J; Wong JI; Su B; Lee CH; Pua CJ; Sim CPY; Ang B; Aw TC; Cook SA; Chin CWL
Circ Cardiovasc Imaging; 2017 Sep; 10(9):e006840. PubMed ID: 28847911
[TBL] [Abstract][Full Text] [Related]
4. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
5. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
6. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.
Rodrigues JC; Amadu AM; Dastidar AG; Szantho GV; Lyen SM; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
Heart; 2016 Oct; 102(20):1671-9. PubMed ID: 27260191
[TBL] [Abstract][Full Text] [Related]
8. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
[TBL] [Abstract][Full Text] [Related]
9. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling.
Wang S; Hu H; Lu M; Sirajuddin A; Li J; An J; Chen X; Yin G; Lan T; Dai L; Zhang Y; Yin X; Song L; Dang A; Kellman P; Arai AE; Zhao S
Eur Radiol; 2017 Nov; 27(11):4620-4630. PubMed ID: 28439652
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
[TBL] [Abstract][Full Text] [Related]
12. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
[TBL] [Abstract][Full Text] [Related]
13. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone.
Kuruvilla S; Janardhanan R; Antkowiak P; Keeley EC; Adenaw N; Brooks J; Epstein FH; Kramer CM; Salerno M
JACC Cardiovasc Imaging; 2015 Feb; 8(2):172-80. PubMed ID: 25577446
[TBL] [Abstract][Full Text] [Related]
14. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
[TBL] [Abstract][Full Text] [Related]
15. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
16. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
17. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B
Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754
[TBL] [Abstract][Full Text] [Related]
19. Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy.
Kwiecinski J; Lennen RJ; Gray GA; Borthwick G; Boswell L; Baker AH; Newby DE; Dweck MR; Jansen MA
J Cardiovasc Magn Reson; 2020 Aug; 22(1):57. PubMed ID: 32758255
[TBL] [Abstract][Full Text] [Related]
20. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
